The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sangeetha Sundaramoorthy
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sangeetha Sundaramoorthy, a promoter/promoter group member of Lotus Eye Hospital And Institute Ltd, has acquired 14,28,571 shares representing 6.8693% of the company's equity capital. The acquisition was done via inter-se transfer, which typically involves transfer between entities within the promoter group. Before the transaction, the acquirer held 28.1391% (58,51,901 shares). After completion, the holding increased to 35.0084% (72,80,472 shares). The transaction was executed on February 27, 2026. The total equity capital of the company remained unchanged at Rs.20,79,63,300.
The promoter group has consolidated its holding by acquiring additional shares, taking total stake to 35%. This represents a meaningful increase in promoter backing but remains well below the 50% threshold or the 25% trigger for open offer requirements.